Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis.
What: Shares of chemical manufacturing company Canexus (TSX: CUS) climbed as high as 13.5% today after its quarterly results topped Bay Street expectations.
So what: The stock has plummeted over the past year on weak caustic soda and hydrochloric prices, but today’s Q4 results — cash operating profit of $24.6 million with distributable cash of $11.7 million — suggest that things are stabilizing. In fact, Canexus noted that demand for bleached pulp in all major end segments remained steady through the end of 2013, giving Mr. Market a bit of optimism over the stock’s ability to rebound.
Now what: Management remains cautiously optimistic about its growth going forward. “Looking ahead to 2014, although we expect continued challenges in the chlor-alkali business for the balance of the year, our NATO manifest business is ramping up transload volumes and should start to generate meaningful results for this business,” said Interim CEO Richard Ott. “Both our North American sodium chlorate and Brazil operations are expected to continue to deliver strong, consistent results this year.”
More important, with the stock still off about 50% from its 52-week highs, there seems like plenty of upside left to buy into that turnaround talk.
Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
Fool contributor Brian Pacampara owns no position in any of the companies mentioned.